Robert C. Green is Professor of Medicine at Harvard Medical School, a medical geneticist and physician-scientist who directs the Genomes2People Research Program at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School. Dr. Green conducts research to accelerate the evidence-based implementation of genomic medicine.
Dr. Green led the first experimental trials disclosing common complex disease risk (REVEAL Study) and the first prospective studies of direct-to-consumer genetic testing services (PGen Study). He currently leads the first randomized trials to explore the implementation of medical sequencing in adults (MedSeq Project) and newborns (BabySeq Project). He has published over 300 scientific papers and in 2014, won the Coriell Prize for Scientific Achievement in Personalized Medicine.
Dr. Green was lead author on the initial recommendations for managing incidental findings in clinical sequencing from the American College of Medical Genetics and Genomics and a co-author on recommendations for managing incidental findings in research biobanks among participants and among family members of participants. He is a member of the National Academies of Science, Engineering and Medicine Committee on the “Evidence Base for Genetic Testing” and a Board Member of the Council for Responsible Genetics.